Atomwise: Abraham Heifets on how AI is redefining drug discovery

On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise is on the fast-track to revolutionizing the healthcare industry. Tune in to hear Atomwise’s fascinating story of how they raised $123 million in funding last year alone, and how the company is using AI to develop pharmaceutical drugs.

You can listen to Atomwise: Abraham Heifets on how AI is redefining drug discovery online on Radio and Podcast. Open the player on this page to stream the available audio.

Atomwise: Abraham Heifets on how AI is redefining drug discovery is an episode from Brains Behind AI by Ari Yacobi.

This episode is 29:17 long.

This episode was published on Apr 12, 2023.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Brains Behind AI when more episodes are available from the podcast feed.